View {title}

Search
!app sctoplatforms theme default menu

RA Watch 5 – COVID-19

March 2021
11.03.2021 COVID-19
11 March 2021 – one year of COVID-19: Reflecting on lessons learnt so far as we move towards the light at the end of the tunnel

Editorial | 11 March 2021: One year of COVID-19
11.03.2021 COVID-19
First lessons learnt about the regulatory aspects of human research related to COVID-19: Perspectives from the SCTO's Regulatory Affairs Platform

Deep Dive | Regulatory lessons learnt by the RA Platform
11.03.2021 COVID-19

Deep Dive | Practices and lessons learnt by the DKF Basel
11.03.2021 COVID-19
The role of swissethics and ethics committees during the COVID-19 pandemic

News About | The role of swissethics and ECs during the COVID-19 pandemic
11.03.2021 COVID-19

Patient organisations: COVID-19 concerns related to human research

11.03.2021 COVID-19

News From | SNSF's response to COVID-19
11.03.2021 COVID-19

News From | Lessons Swissmedic has learnt from the COVID-19 crisis
11.03.2021 COVID-19
Swiss participation in the WHO’s Solidarity trial to test the efficacy of repurposed drugs for treating COVID-19: What the research community has learnt so far

Switzerland's participation in global COVID-19 initiatives
11.03.2021 COVID-19

Switzerland's participation in European COVID-19 initiatives
11.03.2021 COVID-19
Human challenge studies in the time of COVID-19: Pros and cons

Human challenge studies in the time of COVID-19: Pros and cons

Download

You can download a PDF of this entire issue of Regulatory Affairs Watch.
RA Watch 5 – COVID-19 (pdf, 3.88 MB)
!app sctoplatforms theme default enlarge image